Clinical Trial Update: Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96

View source ↗

Summary

A completed Italian observational study evaluating real-world outcomes of unfit acute myeloid leukemia patients treated with venetoclax in combination with hypo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Decitabine (Decitabine)
• Venetoclax (venetoclax)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Acute Myeloid Leukemia | Status: COMPLETED